Insider Trading & Ownership - Shearman Mark S

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Shearman Mark S
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-02-13
Sale
2023-02-15
4:30 pm
Editas Medicine Inc.EDITShearman Mark S
EVP, CHIEF SCIENTIFIC OFFICER
2,790$9.6653$26,96665,559
(Direct)
View
2022-06-15
Sale
2022-06-16
4:15 pm
Editas Medicine Inc.EDITShearman Mark S
EVP, CHIEF SCIENTIFIC OFFICER
5,145$10.06$51,74568,349
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-02-10
Option Award
2022-02-11
4:21 pm
N/A
2032-02-09
Editas Medicine Inc.EDITShearman Mark S
EVP, CHIEF SCIENTIFIC OFFICER
125,107$0166,892
(Direct)
View
2021-12-22
Option Award
2021-12-23
4:10 pm
N/A
N/A
Editas Medicine Inc.EDITShearman Mark S
EVP, Chief Scientific Officer
9,084$041,785
(Direct)
View
2021-06-14
Option Award
2021-06-16
4:19 pm
N/A
2031-06-13
Editas Medicine Inc.EDITShearman Mark S
EVP, Chief Scientific Officer
85,419$085,419
(Direct)
View

Ownership
2021-06-16
4:18 pm
N/A
N/A
Editas Medicine Inc.EDITShearman Mark S
EVP, Chief Scientific Officer
0$00
(Direct)
View
2020-08-15
Tax Withholding
2020-08-18
6:15 pm
N/A
N/A
APPLIED GENETIC TECHNOLOGIES CORPAGTCShearman Mark S
Chief Scientific Officer
5,723$5.7733,277
(Direct)
View
2020-08-05
Option Award
2020-08-07
8:07 pm
N/A
2030-08-05
APPLIED GENETIC TECHNOLOGIES CORPAGTCShearman Mark S
Chief Scientific Officer
50,000$050,000
(Direct)
View
2019-08-15
Option Award
2019-08-19
7:57 pm
N/A
2029-08-15
APPLIED GENETIC TECHNOLOGIES CORPAGTCShearman Mark S
Chief Scientific Officer
91,000$091,000
(Direct)
View